Suppliers / Anjan Drug

Anjan Drug

India 200 employees Updated 9 July 2026

Anjan Drug is an API manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 11 July 2025 as NAI. Customs aggregates show $20.8M of exports covering 170 molecules to 17 destinations in 2025.

2
active US DMFs
0
valid CEPs
4
registered plants 2 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 11 July 2025 NAI US FDA
  • 31 January 2020 VAI US FDA
  • 16 August 2019 VAI US FDA
  • 19 July 2018 VAI US FDA
  • 16 September 2016 VAI US FDA
  • 22 January 2016 VAI US FDA
  • 11 April 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
gummidipoondi 601 201, India Not on file
District Tiruvallur, India 3009402416
Kanchipuram, India Not on file
Alathur, India 3005782924

What they file, and where

Molecule Regulators Docs
Gabapentin US FDA 2
Divalproex SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Gabapentin API

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) None 3
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $4.0M 8
2025 Not reported $20.8M 17
2024 Not reported $22.8M 13
2023 Not reported $22.0M 13

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Anjan Drug

Does Anjan Drug hold a US DMF or a CEP?
Anjan Drug holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Anjan Drug FDA-registered?
2 sites operated by Anjan Drug carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Anjan Drug's last inspection go?
The most recent inspection on record closed on 11 July 2025 as NAI (No Action Indicated: nothing objectionable was found). 7 inspections are on file.
Where does Anjan Drug manufacture?
4 registered sites are on record, in India (Gummidipoondi 601 201, District Tiruvallur and Kanchipuram among others). Every site is listed on this page with the register it came from.
What does Anjan Drug make?
2 molecules are on record against Anjan Drug, including Gabapentin and Divalproex. Each links through to that molecule's full manufacturer list.
Which regulators recognise Anjan Drug's GMP?
Current GMP certificates are on record from CDSCO (India) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Anjan Drug comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 11 July 2025.

Comparable suppliers

Apitoria Pharma shares 1 molecule Hetero shares 1 molecule Olon shares 1 molecule Matrix Pharmacorp shares 1 molecule Granules India shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts